Dechra Pharmaceuticals PLC
DPHAY · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,381 | $5,706 | $6,226 | $5,591 |
| - Cash | $74 | $88 | $121 | $124 |
| + Debt | $505 | $511 | $329 | $317 |
| Enterprise Value | $8,811 | $6,129 | $6,434 | $5,784 |
| Revenue | $384 | $377 | $349 | $332 |
| % Growth | 1.8% | 8% | 5.1% | – |
| Gross Profit | $211 | $219 | $196 | $189 |
| % Margin | 55% | 57.9% | 56.1% | 56.8% |
| EBITDA | $7 | $56 | $71 | $65 |
| % Margin | 1.7% | 14.7% | 20.3% | 19.5% |
| Net Income | -$51 | $23 | $18 | $41 |
| % Margin | -13.1% | 6% | 5% | 12.2% |
| EPS Diluted | -0.44 | 0.199 | 0.16 | 0.38 |
| % Growth | -321.6% | 23.8% | -57.8% | – |
| Operating Cash Flow | $12 | $52 | $35 | $88 |
| Capital Expenditures | -$12 | -$11 | -$9 | -$11 |
| Free Cash Flow | -$0 | $41 | $26 | $77 |